A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test an experimental drug combination of two medications
currently approved by the Food and Drug Administration (FDA) for migraine headache or other
pain. These are called rizatriptan given with acetaminophen.